We've found
887
archived clinical trials in
Autism
We've found
887
archived clinical trials in
Autism
Lurasidone Pediatric Autism Study
Updated: 1/27/2016
A 6-Week, Randomized, Parallel, Double-Blind, Placebo-Controlled, Fixed-Dose, Multicenter Study to Evaluate the Efficacy and Safety of Lurasidone in Children and Adolescent Subjects With Irritability Associated With Autistic Disorder
Status: Enrolling
Updated: 1/27/2016
Lurasidone Pediatric Autism Study
Updated: 1/27/2016
A 6-Week, Randomized, Parallel, Double-Blind, Placebo-Controlled, Fixed-Dose, Multicenter Study to Evaluate the Efficacy and Safety of Lurasidone in Children and Adolescent Subjects With Irritability Associated With Autistic Disorder
Status: Enrolling
Updated: 1/27/2016
Click here to add this to my saved trials
Lurasidone Pediatric Autism Study
Updated: 1/27/2016
A 6-Week, Randomized, Parallel, Double-Blind, Placebo-Controlled, Fixed-Dose, Multicenter Study to Evaluate the Efficacy and Safety of Lurasidone in Children and Adolescent Subjects With Irritability Associated With Autistic Disorder
Status: Enrolling
Updated: 1/27/2016
Lurasidone Pediatric Autism Study
Updated: 1/27/2016
A 6-Week, Randomized, Parallel, Double-Blind, Placebo-Controlled, Fixed-Dose, Multicenter Study to Evaluate the Efficacy and Safety of Lurasidone in Children and Adolescent Subjects With Irritability Associated With Autistic Disorder
Status: Enrolling
Updated: 1/27/2016
Click here to add this to my saved trials
Lurasidone Pediatric Autism Study
Updated: 1/27/2016
A 6-Week, Randomized, Parallel, Double-Blind, Placebo-Controlled, Fixed-Dose, Multicenter Study to Evaluate the Efficacy and Safety of Lurasidone in Children and Adolescent Subjects With Irritability Associated With Autistic Disorder
Status: Enrolling
Updated: 1/27/2016
Lurasidone Pediatric Autism Study
Updated: 1/27/2016
A 6-Week, Randomized, Parallel, Double-Blind, Placebo-Controlled, Fixed-Dose, Multicenter Study to Evaluate the Efficacy and Safety of Lurasidone in Children and Adolescent Subjects With Irritability Associated With Autistic Disorder
Status: Enrolling
Updated: 1/27/2016
Click here to add this to my saved trials
Lurasidone Pediatric Autism Study
Updated: 1/27/2016
A 6-Week, Randomized, Parallel, Double-Blind, Placebo-Controlled, Fixed-Dose, Multicenter Study to Evaluate the Efficacy and Safety of Lurasidone in Children and Adolescent Subjects With Irritability Associated With Autistic Disorder
Status: Enrolling
Updated: 1/27/2016
Lurasidone Pediatric Autism Study
Updated: 1/27/2016
A 6-Week, Randomized, Parallel, Double-Blind, Placebo-Controlled, Fixed-Dose, Multicenter Study to Evaluate the Efficacy and Safety of Lurasidone in Children and Adolescent Subjects With Irritability Associated With Autistic Disorder
Status: Enrolling
Updated: 1/27/2016
Click here to add this to my saved trials
Lurasidone Pediatric Autism Study
Updated: 1/27/2016
A 6-Week, Randomized, Parallel, Double-Blind, Placebo-Controlled, Fixed-Dose, Multicenter Study to Evaluate the Efficacy and Safety of Lurasidone in Children and Adolescent Subjects With Irritability Associated With Autistic Disorder
Status: Enrolling
Updated: 1/27/2016
Lurasidone Pediatric Autism Study
Updated: 1/27/2016
A 6-Week, Randomized, Parallel, Double-Blind, Placebo-Controlled, Fixed-Dose, Multicenter Study to Evaluate the Efficacy and Safety of Lurasidone in Children and Adolescent Subjects With Irritability Associated With Autistic Disorder
Status: Enrolling
Updated: 1/27/2016
Click here to add this to my saved trials
Lurasidone Pediatric Autism Study
Updated: 1/27/2016
A 6-Week, Randomized, Parallel, Double-Blind, Placebo-Controlled, Fixed-Dose, Multicenter Study to Evaluate the Efficacy and Safety of Lurasidone in Children and Adolescent Subjects With Irritability Associated With Autistic Disorder
Status: Enrolling
Updated: 1/27/2016
Lurasidone Pediatric Autism Study
Updated: 1/27/2016
A 6-Week, Randomized, Parallel, Double-Blind, Placebo-Controlled, Fixed-Dose, Multicenter Study to Evaluate the Efficacy and Safety of Lurasidone in Children and Adolescent Subjects With Irritability Associated With Autistic Disorder
Status: Enrolling
Updated: 1/27/2016
Click here to add this to my saved trials
Lurasidone Pediatric Autism Study
Updated: 1/27/2016
A 6-Week, Randomized, Parallel, Double-Blind, Placebo-Controlled, Fixed-Dose, Multicenter Study to Evaluate the Efficacy and Safety of Lurasidone in Children and Adolescent Subjects With Irritability Associated With Autistic Disorder
Status: Enrolling
Updated: 1/27/2016
Lurasidone Pediatric Autism Study
Updated: 1/27/2016
A 6-Week, Randomized, Parallel, Double-Blind, Placebo-Controlled, Fixed-Dose, Multicenter Study to Evaluate the Efficacy and Safety of Lurasidone in Children and Adolescent Subjects With Irritability Associated With Autistic Disorder
Status: Enrolling
Updated: 1/27/2016
Click here to add this to my saved trials
Lurasidone Pediatric Autism Study
Updated: 1/27/2016
A 6-Week, Randomized, Parallel, Double-Blind, Placebo-Controlled, Fixed-Dose, Multicenter Study to Evaluate the Efficacy and Safety of Lurasidone in Children and Adolescent Subjects With Irritability Associated With Autistic Disorder
Status: Enrolling
Updated: 1/27/2016
Lurasidone Pediatric Autism Study
Updated: 1/27/2016
A 6-Week, Randomized, Parallel, Double-Blind, Placebo-Controlled, Fixed-Dose, Multicenter Study to Evaluate the Efficacy and Safety of Lurasidone in Children and Adolescent Subjects With Irritability Associated With Autistic Disorder
Status: Enrolling
Updated: 1/27/2016
Click here to add this to my saved trials
Lurasidone Pediatric Autism Study
Updated: 1/27/2016
A 6-Week, Randomized, Parallel, Double-Blind, Placebo-Controlled, Fixed-Dose, Multicenter Study to Evaluate the Efficacy and Safety of Lurasidone in Children and Adolescent Subjects With Irritability Associated With Autistic Disorder
Status: Enrolling
Updated: 1/27/2016
Lurasidone Pediatric Autism Study
Updated: 1/27/2016
A 6-Week, Randomized, Parallel, Double-Blind, Placebo-Controlled, Fixed-Dose, Multicenter Study to Evaluate the Efficacy and Safety of Lurasidone in Children and Adolescent Subjects With Irritability Associated With Autistic Disorder
Status: Enrolling
Updated: 1/27/2016
Click here to add this to my saved trials
Lurasidone Pediatric Autism Study
Updated: 1/27/2016
A 6-Week, Randomized, Parallel, Double-Blind, Placebo-Controlled, Fixed-Dose, Multicenter Study to Evaluate the Efficacy and Safety of Lurasidone in Children and Adolescent Subjects With Irritability Associated With Autistic Disorder
Status: Enrolling
Updated: 1/27/2016
Lurasidone Pediatric Autism Study
Updated: 1/27/2016
A 6-Week, Randomized, Parallel, Double-Blind, Placebo-Controlled, Fixed-Dose, Multicenter Study to Evaluate the Efficacy and Safety of Lurasidone in Children and Adolescent Subjects With Irritability Associated With Autistic Disorder
Status: Enrolling
Updated: 1/27/2016
Click here to add this to my saved trials
Lurasidone Pediatric Autism Study
Updated: 1/27/2016
A 6-Week, Randomized, Parallel, Double-Blind, Placebo-Controlled, Fixed-Dose, Multicenter Study to Evaluate the Efficacy and Safety of Lurasidone in Children and Adolescent Subjects With Irritability Associated With Autistic Disorder
Status: Enrolling
Updated: 1/27/2016
Lurasidone Pediatric Autism Study
Updated: 1/27/2016
A 6-Week, Randomized, Parallel, Double-Blind, Placebo-Controlled, Fixed-Dose, Multicenter Study to Evaluate the Efficacy and Safety of Lurasidone in Children and Adolescent Subjects With Irritability Associated With Autistic Disorder
Status: Enrolling
Updated: 1/27/2016
Click here to add this to my saved trials
Lurasidone Pediatric Autism Study
Updated: 1/27/2016
A 6-Week, Randomized, Parallel, Double-Blind, Placebo-Controlled, Fixed-Dose, Multicenter Study to Evaluate the Efficacy and Safety of Lurasidone in Children and Adolescent Subjects With Irritability Associated With Autistic Disorder
Status: Enrolling
Updated: 1/27/2016
Lurasidone Pediatric Autism Study
Updated: 1/27/2016
A 6-Week, Randomized, Parallel, Double-Blind, Placebo-Controlled, Fixed-Dose, Multicenter Study to Evaluate the Efficacy and Safety of Lurasidone in Children and Adolescent Subjects With Irritability Associated With Autistic Disorder
Status: Enrolling
Updated: 1/27/2016
Click here to add this to my saved trials
Lurasidone Pediatric Autism Study
Updated: 1/27/2016
A 6-Week, Randomized, Parallel, Double-Blind, Placebo-Controlled, Fixed-Dose, Multicenter Study to Evaluate the Efficacy and Safety of Lurasidone in Children and Adolescent Subjects With Irritability Associated With Autistic Disorder
Status: Enrolling
Updated: 1/27/2016
Lurasidone Pediatric Autism Study
Updated: 1/27/2016
A 6-Week, Randomized, Parallel, Double-Blind, Placebo-Controlled, Fixed-Dose, Multicenter Study to Evaluate the Efficacy and Safety of Lurasidone in Children and Adolescent Subjects With Irritability Associated With Autistic Disorder
Status: Enrolling
Updated: 1/27/2016
Click here to add this to my saved trials
Lurasidone Pediatric Autism Study
Updated: 1/27/2016
A 6-Week, Randomized, Parallel, Double-Blind, Placebo-Controlled, Fixed-Dose, Multicenter Study to Evaluate the Efficacy and Safety of Lurasidone in Children and Adolescent Subjects With Irritability Associated With Autistic Disorder
Status: Enrolling
Updated: 1/27/2016
Lurasidone Pediatric Autism Study
Updated: 1/27/2016
A 6-Week, Randomized, Parallel, Double-Blind, Placebo-Controlled, Fixed-Dose, Multicenter Study to Evaluate the Efficacy and Safety of Lurasidone in Children and Adolescent Subjects With Irritability Associated With Autistic Disorder
Status: Enrolling
Updated: 1/27/2016
Click here to add this to my saved trials
Lurasidone Pediatric Autism Study
Updated: 1/27/2016
A 6-Week, Randomized, Parallel, Double-Blind, Placebo-Controlled, Fixed-Dose, Multicenter Study to Evaluate the Efficacy and Safety of Lurasidone in Children and Adolescent Subjects With Irritability Associated With Autistic Disorder
Status: Enrolling
Updated: 1/27/2016
Lurasidone Pediatric Autism Study
Updated: 1/27/2016
A 6-Week, Randomized, Parallel, Double-Blind, Placebo-Controlled, Fixed-Dose, Multicenter Study to Evaluate the Efficacy and Safety of Lurasidone in Children and Adolescent Subjects With Irritability Associated With Autistic Disorder
Status: Enrolling
Updated: 1/27/2016
Click here to add this to my saved trials
Lurasidone Pediatric Autism Study
Updated: 1/27/2016
A 6-Week, Randomized, Parallel, Double-Blind, Placebo-Controlled, Fixed-Dose, Multicenter Study to Evaluate the Efficacy and Safety of Lurasidone in Children and Adolescent Subjects With Irritability Associated With Autistic Disorder
Status: Enrolling
Updated: 1/27/2016
Lurasidone Pediatric Autism Study
Updated: 1/27/2016
A 6-Week, Randomized, Parallel, Double-Blind, Placebo-Controlled, Fixed-Dose, Multicenter Study to Evaluate the Efficacy and Safety of Lurasidone in Children and Adolescent Subjects With Irritability Associated With Autistic Disorder
Status: Enrolling
Updated: 1/27/2016
Click here to add this to my saved trials
Lurasidone Pediatric Autism Study
Updated: 1/27/2016
A 6-Week, Randomized, Parallel, Double-Blind, Placebo-Controlled, Fixed-Dose, Multicenter Study to Evaluate the Efficacy and Safety of Lurasidone in Children and Adolescent Subjects With Irritability Associated With Autistic Disorder
Status: Enrolling
Updated: 1/27/2016
Lurasidone Pediatric Autism Study
Updated: 1/27/2016
A 6-Week, Randomized, Parallel, Double-Blind, Placebo-Controlled, Fixed-Dose, Multicenter Study to Evaluate the Efficacy and Safety of Lurasidone in Children and Adolescent Subjects With Irritability Associated With Autistic Disorder
Status: Enrolling
Updated: 1/27/2016
Click here to add this to my saved trials
Lurasidone Pediatric Autism Study
Updated: 1/27/2016
A 6-Week, Randomized, Parallel, Double-Blind, Placebo-Controlled, Fixed-Dose, Multicenter Study to Evaluate the Efficacy and Safety of Lurasidone in Children and Adolescent Subjects With Irritability Associated With Autistic Disorder
Status: Enrolling
Updated: 1/27/2016
Lurasidone Pediatric Autism Study
Updated: 1/27/2016
A 6-Week, Randomized, Parallel, Double-Blind, Placebo-Controlled, Fixed-Dose, Multicenter Study to Evaluate the Efficacy and Safety of Lurasidone in Children and Adolescent Subjects With Irritability Associated With Autistic Disorder
Status: Enrolling
Updated: 1/27/2016
Click here to add this to my saved trials
Lurasidone Pediatric Autism Study
Updated: 1/27/2016
A 6-Week, Randomized, Parallel, Double-Blind, Placebo-Controlled, Fixed-Dose, Multicenter Study to Evaluate the Efficacy and Safety of Lurasidone in Children and Adolescent Subjects With Irritability Associated With Autistic Disorder
Status: Enrolling
Updated: 1/27/2016
Lurasidone Pediatric Autism Study
Updated: 1/27/2016
A 6-Week, Randomized, Parallel, Double-Blind, Placebo-Controlled, Fixed-Dose, Multicenter Study to Evaluate the Efficacy and Safety of Lurasidone in Children and Adolescent Subjects With Irritability Associated With Autistic Disorder
Status: Enrolling
Updated: 1/27/2016
Click here to add this to my saved trials
Lurasidone Pediatric Autism Study
Updated: 1/27/2016
A 6-Week, Randomized, Parallel, Double-Blind, Placebo-Controlled, Fixed-Dose, Multicenter Study to Evaluate the Efficacy and Safety of Lurasidone in Children and Adolescent Subjects With Irritability Associated With Autistic Disorder
Status: Enrolling
Updated: 1/27/2016
Lurasidone Pediatric Autism Study
Updated: 1/27/2016
A 6-Week, Randomized, Parallel, Double-Blind, Placebo-Controlled, Fixed-Dose, Multicenter Study to Evaluate the Efficacy and Safety of Lurasidone in Children and Adolescent Subjects With Irritability Associated With Autistic Disorder
Status: Enrolling
Updated: 1/27/2016
Click here to add this to my saved trials
Shared Decision Making to Improve Care and Outcomes for Children With Autism
Updated: 2/4/2016
Shared Decision Making to Improve Care and Outcomes for Children With Autism
Status: Enrolling
Updated: 2/4/2016
Shared Decision Making to Improve Care and Outcomes for Children With Autism
Updated: 2/4/2016
Shared Decision Making to Improve Care and Outcomes for Children With Autism
Status: Enrolling
Updated: 2/4/2016
Click here to add this to my saved trials
A Study of Memantine Hydrochloride (Namenda®) for Cognitive and Behavioral Impairment in Adults With Autism Spectrum Disorders
Updated: 2/26/2016
A Study of Memantine Hydrochloride (Namenda®) for Cognitive and Behavioral Impairment in Adults With Autism Spectrum Disorders
Status: Enrolling
Updated: 2/26/2016
A Study of Memantine Hydrochloride (Namenda®) for Cognitive and Behavioral Impairment in Adults With Autism Spectrum Disorders
Updated: 2/26/2016
A Study of Memantine Hydrochloride (Namenda®) for Cognitive and Behavioral Impairment in Adults With Autism Spectrum Disorders
Status: Enrolling
Updated: 2/26/2016
Click here to add this to my saved trials
Lurasidone Pediatric Pharmacokinetics Study
Updated: 3/10/2016
A Phase 1 Open-Label, Multicenter, Single and Multiple Ascending Dose Study to Evaluate Pharmacokinetics, Safety, and Tolerability of Lurasidone in Subjects 6 to 17 Years Old With Schizophrenia Spectrum, Bipolar Spectrum, Autistic Spectrum Disorder, or Other Psychiatric Disorders
Status: Enrolling
Updated: 3/10/2016
Lurasidone Pediatric Pharmacokinetics Study
Updated: 3/10/2016
A Phase 1 Open-Label, Multicenter, Single and Multiple Ascending Dose Study to Evaluate Pharmacokinetics, Safety, and Tolerability of Lurasidone in Subjects 6 to 17 Years Old With Schizophrenia Spectrum, Bipolar Spectrum, Autistic Spectrum Disorder, or Other Psychiatric Disorders
Status: Enrolling
Updated: 3/10/2016
Click here to add this to my saved trials
Lurasidone Pediatric Pharmacokinetics Study
Updated: 3/10/2016
A Phase 1 Open-Label, Multicenter, Single and Multiple Ascending Dose Study to Evaluate Pharmacokinetics, Safety, and Tolerability of Lurasidone in Subjects 6 to 17 Years Old With Schizophrenia Spectrum, Bipolar Spectrum, Autistic Spectrum Disorder, or Other Psychiatric Disorders
Status: Enrolling
Updated: 3/10/2016
Lurasidone Pediatric Pharmacokinetics Study
Updated: 3/10/2016
A Phase 1 Open-Label, Multicenter, Single and Multiple Ascending Dose Study to Evaluate Pharmacokinetics, Safety, and Tolerability of Lurasidone in Subjects 6 to 17 Years Old With Schizophrenia Spectrum, Bipolar Spectrum, Autistic Spectrum Disorder, or Other Psychiatric Disorders
Status: Enrolling
Updated: 3/10/2016
Click here to add this to my saved trials
Lurasidone Pediatric Pharmacokinetics Study
Updated: 3/10/2016
A Phase 1 Open-Label, Multicenter, Single and Multiple Ascending Dose Study to Evaluate Pharmacokinetics, Safety, and Tolerability of Lurasidone in Subjects 6 to 17 Years Old With Schizophrenia Spectrum, Bipolar Spectrum, Autistic Spectrum Disorder, or Other Psychiatric Disorders
Status: Enrolling
Updated: 3/10/2016
Lurasidone Pediatric Pharmacokinetics Study
Updated: 3/10/2016
A Phase 1 Open-Label, Multicenter, Single and Multiple Ascending Dose Study to Evaluate Pharmacokinetics, Safety, and Tolerability of Lurasidone in Subjects 6 to 17 Years Old With Schizophrenia Spectrum, Bipolar Spectrum, Autistic Spectrum Disorder, or Other Psychiatric Disorders
Status: Enrolling
Updated: 3/10/2016
Click here to add this to my saved trials
Lurasidone Pediatric Pharmacokinetics Study
Updated: 3/10/2016
A Phase 1 Open-Label, Multicenter, Single and Multiple Ascending Dose Study to Evaluate Pharmacokinetics, Safety, and Tolerability of Lurasidone in Subjects 6 to 17 Years Old With Schizophrenia Spectrum, Bipolar Spectrum, Autistic Spectrum Disorder, or Other Psychiatric Disorders
Status: Enrolling
Updated: 3/10/2016
Lurasidone Pediatric Pharmacokinetics Study
Updated: 3/10/2016
A Phase 1 Open-Label, Multicenter, Single and Multiple Ascending Dose Study to Evaluate Pharmacokinetics, Safety, and Tolerability of Lurasidone in Subjects 6 to 17 Years Old With Schizophrenia Spectrum, Bipolar Spectrum, Autistic Spectrum Disorder, or Other Psychiatric Disorders
Status: Enrolling
Updated: 3/10/2016
Click here to add this to my saved trials
Lurasidone Pediatric Pharmacokinetics Study
Updated: 3/10/2016
A Phase 1 Open-Label, Multicenter, Single and Multiple Ascending Dose Study to Evaluate Pharmacokinetics, Safety, and Tolerability of Lurasidone in Subjects 6 to 17 Years Old With Schizophrenia Spectrum, Bipolar Spectrum, Autistic Spectrum Disorder, or Other Psychiatric Disorders
Status: Enrolling
Updated: 3/10/2016
Lurasidone Pediatric Pharmacokinetics Study
Updated: 3/10/2016
A Phase 1 Open-Label, Multicenter, Single and Multiple Ascending Dose Study to Evaluate Pharmacokinetics, Safety, and Tolerability of Lurasidone in Subjects 6 to 17 Years Old With Schizophrenia Spectrum, Bipolar Spectrum, Autistic Spectrum Disorder, or Other Psychiatric Disorders
Status: Enrolling
Updated: 3/10/2016
Click here to add this to my saved trials
Lurasidone Pediatric Pharmacokinetics Study
Updated: 3/10/2016
A Phase 1 Open-Label, Multicenter, Single and Multiple Ascending Dose Study to Evaluate Pharmacokinetics, Safety, and Tolerability of Lurasidone in Subjects 6 to 17 Years Old With Schizophrenia Spectrum, Bipolar Spectrum, Autistic Spectrum Disorder, or Other Psychiatric Disorders
Status: Enrolling
Updated: 3/10/2016
Lurasidone Pediatric Pharmacokinetics Study
Updated: 3/10/2016
A Phase 1 Open-Label, Multicenter, Single and Multiple Ascending Dose Study to Evaluate Pharmacokinetics, Safety, and Tolerability of Lurasidone in Subjects 6 to 17 Years Old With Schizophrenia Spectrum, Bipolar Spectrum, Autistic Spectrum Disorder, or Other Psychiatric Disorders
Status: Enrolling
Updated: 3/10/2016
Click here to add this to my saved trials
Lurasidone Pediatric Pharmacokinetics Study
Updated: 3/10/2016
A Phase 1 Open-Label, Multicenter, Single and Multiple Ascending Dose Study to Evaluate Pharmacokinetics, Safety, and Tolerability of Lurasidone in Subjects 6 to 17 Years Old With Schizophrenia Spectrum, Bipolar Spectrum, Autistic Spectrum Disorder, or Other Psychiatric Disorders
Status: Enrolling
Updated: 3/10/2016
Lurasidone Pediatric Pharmacokinetics Study
Updated: 3/10/2016
A Phase 1 Open-Label, Multicenter, Single and Multiple Ascending Dose Study to Evaluate Pharmacokinetics, Safety, and Tolerability of Lurasidone in Subjects 6 to 17 Years Old With Schizophrenia Spectrum, Bipolar Spectrum, Autistic Spectrum Disorder, or Other Psychiatric Disorders
Status: Enrolling
Updated: 3/10/2016
Click here to add this to my saved trials
Lurasidone Pediatric Pharmacokinetics Study
Updated: 3/10/2016
A Phase 1 Open-Label, Multicenter, Single and Multiple Ascending Dose Study to Evaluate Pharmacokinetics, Safety, and Tolerability of Lurasidone in Subjects 6 to 17 Years Old With Schizophrenia Spectrum, Bipolar Spectrum, Autistic Spectrum Disorder, or Other Psychiatric Disorders
Status: Enrolling
Updated: 3/10/2016
Lurasidone Pediatric Pharmacokinetics Study
Updated: 3/10/2016
A Phase 1 Open-Label, Multicenter, Single and Multiple Ascending Dose Study to Evaluate Pharmacokinetics, Safety, and Tolerability of Lurasidone in Subjects 6 to 17 Years Old With Schizophrenia Spectrum, Bipolar Spectrum, Autistic Spectrum Disorder, or Other Psychiatric Disorders
Status: Enrolling
Updated: 3/10/2016
Click here to add this to my saved trials
Lurasidone Pediatric Pharmacokinetics Study
Updated: 3/10/2016
A Phase 1 Open-Label, Multicenter, Single and Multiple Ascending Dose Study to Evaluate Pharmacokinetics, Safety, and Tolerability of Lurasidone in Subjects 6 to 17 Years Old With Schizophrenia Spectrum, Bipolar Spectrum, Autistic Spectrum Disorder, or Other Psychiatric Disorders
Status: Enrolling
Updated: 3/10/2016
Lurasidone Pediatric Pharmacokinetics Study
Updated: 3/10/2016
A Phase 1 Open-Label, Multicenter, Single and Multiple Ascending Dose Study to Evaluate Pharmacokinetics, Safety, and Tolerability of Lurasidone in Subjects 6 to 17 Years Old With Schizophrenia Spectrum, Bipolar Spectrum, Autistic Spectrum Disorder, or Other Psychiatric Disorders
Status: Enrolling
Updated: 3/10/2016
Click here to add this to my saved trials
Lurasidone Pediatric Pharmacokinetics Study
Updated: 3/10/2016
A Phase 1 Open-Label, Multicenter, Single and Multiple Ascending Dose Study to Evaluate Pharmacokinetics, Safety, and Tolerability of Lurasidone in Subjects 6 to 17 Years Old With Schizophrenia Spectrum, Bipolar Spectrum, Autistic Spectrum Disorder, or Other Psychiatric Disorders
Status: Enrolling
Updated: 3/10/2016
Lurasidone Pediatric Pharmacokinetics Study
Updated: 3/10/2016
A Phase 1 Open-Label, Multicenter, Single and Multiple Ascending Dose Study to Evaluate Pharmacokinetics, Safety, and Tolerability of Lurasidone in Subjects 6 to 17 Years Old With Schizophrenia Spectrum, Bipolar Spectrum, Autistic Spectrum Disorder, or Other Psychiatric Disorders
Status: Enrolling
Updated: 3/10/2016
Click here to add this to my saved trials
Acupressure and Acupuncture as an Intervention With Children With Autism II
Updated: 3/21/2016
Investigating the Use of Acupressure and Acupuncture With Children With Autism II
Status: Enrolling
Updated: 3/21/2016
Acupressure and Acupuncture as an Intervention With Children With Autism II
Updated: 3/21/2016
Investigating the Use of Acupressure and Acupuncture With Children With Autism II
Status: Enrolling
Updated: 3/21/2016
Click here to add this to my saved trials
Examining the Efficacy of Mattress Technology in Improving the Sleep Quality of Children With ASD
Updated: 4/11/2016
A Randomized, Cross-Over Study of the Efficacy of Mattress Technology in Improving the Sleep Quality of Children With ASD and Sleep Disturbances
Status: Enrolling
Updated: 4/11/2016
Examining the Efficacy of Mattress Technology in Improving the Sleep Quality of Children With ASD
Updated: 4/11/2016
A Randomized, Cross-Over Study of the Efficacy of Mattress Technology in Improving the Sleep Quality of Children With ASD and Sleep Disturbances
Status: Enrolling
Updated: 4/11/2016
Click here to add this to my saved trials
A Multi-site Double-blind Placebo-controlled Trial of Memantine Versus Placebo in Children With Autism (MEM)
Updated: 4/12/2016
A Multi-site Double-blind Placebo-controlled Trial of Memantine Versus Placebo in Children With Autism Targeting Memory and Motor Planning
Status: Enrolling
Updated: 4/12/2016
A Multi-site Double-blind Placebo-controlled Trial of Memantine Versus Placebo in Children With Autism (MEM)
Updated: 4/12/2016
A Multi-site Double-blind Placebo-controlled Trial of Memantine Versus Placebo in Children With Autism Targeting Memory and Motor Planning
Status: Enrolling
Updated: 4/12/2016
Click here to add this to my saved trials
A Multi-site Double-blind Placebo-controlled Trial of Memantine Versus Placebo in Children With Autism (MEM)
Updated: 4/12/2016
A Multi-site Double-blind Placebo-controlled Trial of Memantine Versus Placebo in Children With Autism Targeting Memory and Motor Planning
Status: Enrolling
Updated: 4/12/2016
A Multi-site Double-blind Placebo-controlled Trial of Memantine Versus Placebo in Children With Autism (MEM)
Updated: 4/12/2016
A Multi-site Double-blind Placebo-controlled Trial of Memantine Versus Placebo in Children With Autism Targeting Memory and Motor Planning
Status: Enrolling
Updated: 4/12/2016
Click here to add this to my saved trials
Intranasal Oxytocin for the Treatment of Children and Adolescents With Autism Spectrum Disorders (ASD)
Updated: 4/12/2016
Intranasal Oxytocin for the Treatment of Children and Adolescents With Autism
Status: Enrolling
Updated: 4/12/2016
Intranasal Oxytocin for the Treatment of Children and Adolescents With Autism Spectrum Disorders (ASD)
Updated: 4/12/2016
Intranasal Oxytocin for the Treatment of Children and Adolescents With Autism
Status: Enrolling
Updated: 4/12/2016
Click here to add this to my saved trials
Intranasal Oxytocin for the Treatment of Children and Adolescents With Autism Spectrum Disorders (ASD)
Updated: 4/12/2016
Intranasal Oxytocin for the Treatment of Children and Adolescents With Autism
Status: Enrolling
Updated: 4/12/2016
Intranasal Oxytocin for the Treatment of Children and Adolescents With Autism Spectrum Disorders (ASD)
Updated: 4/12/2016
Intranasal Oxytocin for the Treatment of Children and Adolescents With Autism
Status: Enrolling
Updated: 4/12/2016
Click here to add this to my saved trials
Brain Connectivity in Neurodevelopmental Disorders in Response to Treatment
Updated: 4/14/2016
Characterization of Potential Biomarkers to Assess Brain Connectivity in Neurodevelopmental Disorders in Response to Treatment
Status: Enrolling
Updated: 4/14/2016
Brain Connectivity in Neurodevelopmental Disorders in Response to Treatment
Updated: 4/14/2016
Characterization of Potential Biomarkers to Assess Brain Connectivity in Neurodevelopmental Disorders in Response to Treatment
Status: Enrolling
Updated: 4/14/2016
Click here to add this to my saved trials
Investigation of Neuroserpin as an Autism Candidate Gene
Updated: 4/18/2016
Investigation of Neuroserpin as an Autism Candidate Gene
Status: Enrolling
Updated: 4/18/2016
Investigation of Neuroserpin as an Autism Candidate Gene
Updated: 4/18/2016
Investigation of Neuroserpin as an Autism Candidate Gene
Status: Enrolling
Updated: 4/18/2016
Click here to add this to my saved trials
University of California, San Diego (UCSD) Suramin Treatment Trial for Autism
Updated: 4/25/2016
The UCSD Suramin Autism Treatment Trial
Status: Enrolling
Updated: 4/25/2016
University of California, San Diego (UCSD) Suramin Treatment Trial for Autism
Updated: 4/25/2016
The UCSD Suramin Autism Treatment Trial
Status: Enrolling
Updated: 4/25/2016
Click here to add this to my saved trials
Improving Hospitalizations for Children With ASD
Updated: 4/26/2016
Improving Hospitalizations for Children With ASD: Testing the Cost and Clinical Efficacy of Integrated Behavioral Intervention
Status: Enrolling
Updated: 4/26/2016
Improving Hospitalizations for Children With ASD
Updated: 4/26/2016
Improving Hospitalizations for Children With ASD: Testing the Cost and Clinical Efficacy of Integrated Behavioral Intervention
Status: Enrolling
Updated: 4/26/2016
Click here to add this to my saved trials
iPad Application to Treat Prosodic Deficits in Students With Communication Disorders
Updated: 6/13/2016
Handheld Technology for Speech Development in Students With Autism Spectrum Disorders
Status: Enrolling
Updated: 6/13/2016
iPad Application to Treat Prosodic Deficits in Students With Communication Disorders
Updated: 6/13/2016
Handheld Technology for Speech Development in Students With Autism Spectrum Disorders
Status: Enrolling
Updated: 6/13/2016
Click here to add this to my saved trials
Study to Assess the Janssen Autism Knowledge Engine in Participants With Autism Spectrum Disorder and in a Normally Developing Cohort
Updated: 11/21/2016
A Study to Assess the Janssen Autism Knowledge Engine in Children and Adults With Autism Spectrum Disorder and in a Normally Developing Cohort
Status: Enrolling
Updated: 11/21/2016
Study to Assess the Janssen Autism Knowledge Engine in Participants With Autism Spectrum Disorder and in a Normally Developing Cohort
Updated: 11/21/2016
A Study to Assess the Janssen Autism Knowledge Engine in Children and Adults With Autism Spectrum Disorder and in a Normally Developing Cohort
Status: Enrolling
Updated: 11/21/2016
Click here to add this to my saved trials
Study to Assess the Janssen Autism Knowledge Engine in Participants With Autism Spectrum Disorder and in a Normally Developing Cohort
Updated: 11/21/2016
A Study to Assess the Janssen Autism Knowledge Engine in Children and Adults With Autism Spectrum Disorder and in a Normally Developing Cohort
Status: Enrolling
Updated: 11/21/2016
Study to Assess the Janssen Autism Knowledge Engine in Participants With Autism Spectrum Disorder and in a Normally Developing Cohort
Updated: 11/21/2016
A Study to Assess the Janssen Autism Knowledge Engine in Children and Adults With Autism Spectrum Disorder and in a Normally Developing Cohort
Status: Enrolling
Updated: 11/21/2016
Click here to add this to my saved trials
Study to Assess the Janssen Autism Knowledge Engine in Participants With Autism Spectrum Disorder and in a Normally Developing Cohort
Updated: 11/21/2016
A Study to Assess the Janssen Autism Knowledge Engine in Children and Adults With Autism Spectrum Disorder and in a Normally Developing Cohort
Status: Enrolling
Updated: 11/21/2016
Study to Assess the Janssen Autism Knowledge Engine in Participants With Autism Spectrum Disorder and in a Normally Developing Cohort
Updated: 11/21/2016
A Study to Assess the Janssen Autism Knowledge Engine in Children and Adults With Autism Spectrum Disorder and in a Normally Developing Cohort
Status: Enrolling
Updated: 11/21/2016
Click here to add this to my saved trials
Study to Assess the Janssen Autism Knowledge Engine in Participants With Autism Spectrum Disorder and in a Normally Developing Cohort
Updated: 11/21/2016
A Study to Assess the Janssen Autism Knowledge Engine in Children and Adults With Autism Spectrum Disorder and in a Normally Developing Cohort
Status: Enrolling
Updated: 11/21/2016
Study to Assess the Janssen Autism Knowledge Engine in Participants With Autism Spectrum Disorder and in a Normally Developing Cohort
Updated: 11/21/2016
A Study to Assess the Janssen Autism Knowledge Engine in Children and Adults With Autism Spectrum Disorder and in a Normally Developing Cohort
Status: Enrolling
Updated: 11/21/2016
Click here to add this to my saved trials
Study to Assess the Janssen Autism Knowledge Engine in Participants With Autism Spectrum Disorder and in a Normally Developing Cohort
Updated: 11/21/2016
A Study to Assess the Janssen Autism Knowledge Engine in Children and Adults With Autism Spectrum Disorder and in a Normally Developing Cohort
Status: Enrolling
Updated: 11/21/2016
Study to Assess the Janssen Autism Knowledge Engine in Participants With Autism Spectrum Disorder and in a Normally Developing Cohort
Updated: 11/21/2016
A Study to Assess the Janssen Autism Knowledge Engine in Children and Adults With Autism Spectrum Disorder and in a Normally Developing Cohort
Status: Enrolling
Updated: 11/21/2016
Click here to add this to my saved trials
Study to Assess the Janssen Autism Knowledge Engine in Participants With Autism Spectrum Disorder and in a Normally Developing Cohort
Updated: 11/21/2016
A Study to Assess the Janssen Autism Knowledge Engine in Children and Adults With Autism Spectrum Disorder and in a Normally Developing Cohort
Status: Enrolling
Updated: 11/21/2016
Study to Assess the Janssen Autism Knowledge Engine in Participants With Autism Spectrum Disorder and in a Normally Developing Cohort
Updated: 11/21/2016
A Study to Assess the Janssen Autism Knowledge Engine in Children and Adults With Autism Spectrum Disorder and in a Normally Developing Cohort
Status: Enrolling
Updated: 11/21/2016
Click here to add this to my saved trials
Study to Assess the Janssen Autism Knowledge Engine in Participants With Autism Spectrum Disorder and in a Normally Developing Cohort
Updated: 11/21/2016
A Study to Assess the Janssen Autism Knowledge Engine in Children and Adults With Autism Spectrum Disorder and in a Normally Developing Cohort
Status: Enrolling
Updated: 11/21/2016
Study to Assess the Janssen Autism Knowledge Engine in Participants With Autism Spectrum Disorder and in a Normally Developing Cohort
Updated: 11/21/2016
A Study to Assess the Janssen Autism Knowledge Engine in Children and Adults With Autism Spectrum Disorder and in a Normally Developing Cohort
Status: Enrolling
Updated: 11/21/2016
Click here to add this to my saved trials